NLS Pharmaceutics AG

NASDAQ: NLSP · Real-Time Price · USD
2.54
-0.07 (-2.68%)
At close: Aug 15, 2025, 3:59 PM
2.58
1.58%
After-hours: Aug 15, 2025, 07:55 PM EDT

NLS Pharmaceutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
897.68K 8.95M 5.43M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
16.89K 12.14K 12.04K
Receivables
10.66K n/a n/a
Inventory
n/a -41.24K -38.55K
Other Current Assets
845.7K n/a n/a
Total Current Assets
1.82M 9.25M 5.72M
Property-Plant & Equipment
6.69K 18.1K 29.51K
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
23.58K 30.25K 41.55K
Total Assets
1.85M 9.28M 5.76M
Account Payables
4.63M 2.37M 1.74M
Deferred Revenue
n/a n/a 2.5B
Short-Term Debt
1.63M n/a n/a
Other Current Liabilities
112.64K 8.89K 10.08K
Total Current Liabilities
7.92M 3.36M 2.4M
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
260.69K 136.12K 318.89K
Total Long-Term Liabilities
2.76M 2.64M 2.82M
Total Liabilities
10.68M 6M 5.22M
Total Debt
1.63M n/a n/a
Common Stock
733.41K 668.55K 344.44K
Retained Earnings
-70.37M -58.2M -41.71M
Comprehensive Income
-158.07K -50.79K -151.74K
Shareholders Equity
-8.83M 3.28M 542.39K
Total Investments
n/a n/a n/a